Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cranberry refers to the fruit of the North American evergreen shrub *Vaccinium macrocarpon*. It is widely used as a dietary supplement and herbal product. The primary indication for medicinal use is the prevention (not treatment) of urinary tract infections (UTIs), particularly in adult females and people prone to recurrent UTIs[3][5][7]. Other uses with limited or unproven evidence include reducing symptoms of an enlarged prostate and reducing urine odor in incontinent patients[3][7]. The proposed mechanism of action involves compounds in cranberries—mainly fructose and proanthocyanidins (PACs)—which inhibit the adhesion of *Escherichia coli* bacteria to uroepithelial cells by binding to bacterial fimbriae. This anti-adhesion effect prevents colonization and infection of the urinary tract mucosa[6][8]. Additional mechanisms may include conformational changes in bacterial surface molecules that reduce virulence[6][8]. Cranberries are available as juice drinks (often diluted), capsules/tablets containing dried extract or powder. There are no regulated manufacturing standards for many supplements; efficacy varies between products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cranberry.